Posted inBiotechnology
GSK’s ‘functional cure’ for hep B proves worth in phase 3 trials setting up approval push
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3…
Posted inBiotechnology
Hutchmed heats up autoimmune race with phase 3 win, teeing up China filing
A phase 3 trial of Hutchmed’s autoimmune disease candidate sovleplenib has hit its primary endpoint, delivering a boost to an asset…
Posted inBiotechnology
Optoretinography Tracks Fast Rod Movement Post-Rhodopsin Activation
In a groundbreaking advancement for vision science, a team of researchers has unveiled astonishing insights into the rapid movement of…
Posted inBiotechnology
DNA Breaks Boost RORγt, Drive Th17 Autoimmunity
In a groundbreaking study poised to reshape our understanding of autoimmune diseases, researchers have unveiled a previously unrecognized mechanism by…
Posted inBiotechnology
Canagliflozin Controls Fat Cell Lipolysis Independently
In a groundbreaking study that may redefine our understanding of metabolic regulation and diabetes treatment, researchers have uncovered a novel…
Posted inBiotechnology
Fosfomycin Resistance Rampant in ST11 Klebsiella Pneumoniae
In a groundbreaking study that has raised alarm bells in the medical community, researchers led by Li et al. have…
Posted inBiotechnology
Organoids: A New Hope for Pancreatic Cancer Treatment
In a groundbreaking study that illuminates the complex landscape of pancreatic cancer research, a dedicated team of scientists has unveiled…
Posted inBiotechnology
Tetrandrine Blocks SARS-CoV-2 via Cholesterol, IGF
In an era still grappling with the pervasive threat of SARS-CoV-2, the virus responsible for the devastating COVID-19 pandemic, the…
Posted inBiotechnology
Widespread Rise in Australian Tree Deaths
Across the Australian continent, a silent yet profound transformation is unfurling within its vast and diverse forest landscapes. Recent comprehensive…
Posted inMedical Technology
Staar Surgical’s takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now…